Asthma Drugs Market Growth Fueled by Biologic Therapies at 3.98%...

agregó una foto Other

2026-08-26 07:33:04 -

Asthma Drugs Market Growth Fueled by Biologic Therapies at 3.98% CAGR Through 2033

Asthma drugs delivered via dry powder inhalers (DPIs), pressurized metered-dose inhalers (pMDIs), or soft mist inhalers rely on proper inhalation technique to achieve optimal lung deposition. Utilizing a spacer chamber with pMDIs reduces drug deposition in the mouth and throat, decreasing risks of oral candidiasis (thrush) and hoarseness. Spacers also ensure maximum medication reaches the lower...

0 Commentarios 0 Acciones 224 Views 0 Vista previa